Osteoarthritis-Related Walking Disability and Arterial Stiffness: Results From a Cross-Sectional Study.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
02 2019
Historique:
received: 20 10 2017
accepted: 15 05 2018
pubmed: 6 7 2018
medline: 15 10 2019
entrez: 6 7 2018
Statut: ppublish

Résumé

To compare the 6-minute walking distance (6MWD) in a population-based cohort of patients with osteoarthritis (OA) with that in matched peers from the general population, and to explore the associations between walking ability and risk of cardiovascular disease (CVD) in the OA cohort. This cross-sectional study included individuals (ages 40-80 years) who had self-reported OA (n = 500) in a previous population-based study and age- and sex-matched peers from the general population (n = 235). Clinical examinations of the patients with OA included classification according to the American College of Rheumatology criteria, blood sampling, and measuring arterial stiffness (PWV; pulse wave velocity). Group differences in the 6MWD were calculated with t-tests. The association between walking ability and CVD risk in the OA cohort was examined using multivariate regression models. In the age-stratified analyses, the largest mean difference in the 6MWD was observed in the youngest age groups (40-49 years); female patients in the OA group walked 84.6 fewer meters compared with the reference group (579.4 meters and 663.9 meters, respectively; P < 0.001), and male patients walked 88.3 fewer meters compared with the reference group (619.9 meters and 708.3 meters, respectively; P = 0.001). In the OA group, the 6MWD was significantly associated with PWV in the adjusted analysis (P = 0.001); an increase in the walking distance of 100 meters corresponded to a reduction in PWV of 0.3 meters/second. Even at age 40 years, patients with OA had a significantly shorter mean walking distance compared with their matched peers, underlining the importance of an early clinical approach to OA. Furthermore, in the OA group, the 6MWD was significantly associated with arterial stiffness, suggesting that walking ability is important for the CVD risk profile in patients with OA.

Identifiants

pubmed: 29975013
doi: 10.1002/acr.23697
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-258

Subventions

Organisme : South-Eastern Norway Regional Health Authority Osteoarthritis Research Group
Pays : International
Organisme : Anders Jahre Humanitarian Foundation
Pays : International
Organisme : Dr. Trygve Gythfeldt and Wife's Research Fund
Pays : International
Organisme : Norwegian Rheumatism Association Research Fund
Pays : International

Informations de copyright

© 2018, American College of Rheumatology.

Auteurs

Kenth L Joseph (KL)

Diakonhjemmet Hospital, Oslo, Norway.

Kåre B Hagen (KB)

Diakonhjemmet Hospital, Oslo, Norway.

Anne T Tveter (AT)

Diakonhjemmet Hospital, Oslo, Norway.

Karin Magnusson (K)

Diakonhjemmet Hospital, Oslo, Norway and Lund University, Lund, Sweden.

Sella A Provan (SA)

Diakonhjemmet Hospital, Oslo, Norway.

Hanne Dagfinrud (H)

Diakonhjemmet Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH